The pro-angiogenic factor CCN1 enhances the re-endothelialization of biological vascularized matrices in vitro

Aims A problem in generating artificial tissues is supplying nutrients to cells within 3D constructs. The use of a decellularized biological vascularized matrix with preserved pedicles (BioVaM), as a scaffold, appears to aid the generation of perfusable tissue constructs in vitro. To prevent vessel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cardiovascular research 2010-03, Vol.85 (4), p.806-813
Hauptverfasser: Bär, Antonia, Dorfman, Suzanne E., Fischer, Philipp, Hilfiker-Kleiner, Denise, Cebotari, Serghei, Tudorache, Igor, Suprunov, Marc, Haverich, Axel, Hilfiker, Andres
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 813
container_issue 4
container_start_page 806
container_title Cardiovascular research
container_volume 85
creator Bär, Antonia
Dorfman, Suzanne E.
Fischer, Philipp
Hilfiker-Kleiner, Denise
Cebotari, Serghei
Tudorache, Igor
Suprunov, Marc
Haverich, Axel
Hilfiker, Andres
description Aims A problem in generating artificial tissues is supplying nutrients to cells within 3D constructs. The use of a decellularized biological vascularized matrix with preserved pedicles (BioVaM), as a scaffold, appears to aid the generation of perfusable tissue constructs in vitro. To prevent vessel occlusion upon implantation, a functional endothelium must line the graft vessel bed. Here we tested whether the pro-angiogenic factor CCN1 could improve the re-endothelialization of BioVaM in vitro. Methods and results BioVaM vessel beds were incubated with 100 ng/mL recombinant human CCN1. Human cord blood endothelial cells (hCBEC) were analysed with respect to adhesion behaviour upon CCN1 exposure and seeded onto vessel structures of CCN1 exposed BioVaM (cBioVaM). BioVaMs were fixed in a bioreactor and perfusion cultured for 4 and 14 days (d). BioVaM without CCN1 treatment served as controls. Initial seeding success and endothelialization progression were monitored by fluorescence‐labelled hCBEC. During construct cultivation, pH and lactate production were measured. Degree of endothelialization and characterization of seeded cells, with respect to endothelial markers, were investigated histologically. BioVaM vessel structures showed a 78 ± 17% increase of attached cells when pre-treated with CCN1. Evaluation of re-endothelialization (arbitrary units) was 4.0 ± 0.8 and 2.6 ± 0.8 after 4 d, and 5.0 ± 0.0 and 3.0 ± 0.5 after 14 d in cBioVaM vs. BioVaM, respectively. On day 14, lactate concentration, an indicator of metabolic activity, was increased 12-fold in cBioVaM relative to BioVaM. A preserved endothelial phenotype of seeded cells was verified in all cultures by acetylated low density lipoprotein uptake and positive immunohistochemistry against von Willebrand factor, endothelial nitric oxide synthase, and CD31. Conclusion Coating of decellularized vessel structures with CCN1 supports adhesion of hCBEC and enhances re-endothelialization of BioVaM. Perfusable, endothelialized constructs may aid in solving the problem of nourishing cells inside 3D tissue‐engineered constructs.
doi_str_mv 10.1093/cvr/cvp370
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_734023849</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/cvr/cvp370</oup_id><sourcerecordid>734023849</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-4548c052e33bfdd363aafc3dddfe63661c9791601ad9733b4318be068925468f3</originalsourceid><addsrcrecordid>eNp90E1rFDEYB_Agit1WL34AyUUEYfTJ22TmKIt2haII1YqXkM3LNppN1mRmsf30puzS3jyEJPDLE_5_hF4QeEtgZO_MvrS1YxIeoQWRQnSMcvEYLQBg6HrWsxN0WuuvdhVC8qfohIwjBcJggdLltcO7kjudNiFvXAoGe22mXPBy-Zlgl651Mq7iqbniOpdsbscYdAy3ego54ezxOuSYN8HoiPe6mjnqEm6dxVs9lXD3OiS8D1PJz9ATr2N1z4_7Gfr28cPlctVdfDn_tHx_0RlOYeq44IMBQR1ja29tS6C1N8xa613L0xMzypH0QLQdZTOckWHtoB9GKng_eHaGXh_mtmh_ZlcntQ3VuBh1cnmuSjIOlA18bPLNQZqSay3Oq10JW11uFAF1V69q9apDvQ2_PI6d11tnH-ixzwZeHUGrQUdfWnmh3jtKOQGg8sHleff_D7uDC3Vyf--lLr9VL5kUavXjp_q64ldX8P1cEfYPBkqgUw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>734023849</pqid></control><display><type>article</type><title>The pro-angiogenic factor CCN1 enhances the re-endothelialization of biological vascularized matrices in vitro</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Bär, Antonia ; Dorfman, Suzanne E. ; Fischer, Philipp ; Hilfiker-Kleiner, Denise ; Cebotari, Serghei ; Tudorache, Igor ; Suprunov, Marc ; Haverich, Axel ; Hilfiker, Andres</creator><creatorcontrib>Bär, Antonia ; Dorfman, Suzanne E. ; Fischer, Philipp ; Hilfiker-Kleiner, Denise ; Cebotari, Serghei ; Tudorache, Igor ; Suprunov, Marc ; Haverich, Axel ; Hilfiker, Andres</creatorcontrib><description>Aims A problem in generating artificial tissues is supplying nutrients to cells within 3D constructs. The use of a decellularized biological vascularized matrix with preserved pedicles (BioVaM), as a scaffold, appears to aid the generation of perfusable tissue constructs in vitro. To prevent vessel occlusion upon implantation, a functional endothelium must line the graft vessel bed. Here we tested whether the pro-angiogenic factor CCN1 could improve the re-endothelialization of BioVaM in vitro. Methods and results BioVaM vessel beds were incubated with 100 ng/mL recombinant human CCN1. Human cord blood endothelial cells (hCBEC) were analysed with respect to adhesion behaviour upon CCN1 exposure and seeded onto vessel structures of CCN1 exposed BioVaM (cBioVaM). BioVaMs were fixed in a bioreactor and perfusion cultured for 4 and 14 days (d). BioVaM without CCN1 treatment served as controls. Initial seeding success and endothelialization progression were monitored by fluorescence‐labelled hCBEC. During construct cultivation, pH and lactate production were measured. Degree of endothelialization and characterization of seeded cells, with respect to endothelial markers, were investigated histologically. BioVaM vessel structures showed a 78 ± 17% increase of attached cells when pre-treated with CCN1. Evaluation of re-endothelialization (arbitrary units) was 4.0 ± 0.8 and 2.6 ± 0.8 after 4 d, and 5.0 ± 0.0 and 3.0 ± 0.5 after 14 d in cBioVaM vs. BioVaM, respectively. On day 14, lactate concentration, an indicator of metabolic activity, was increased 12-fold in cBioVaM relative to BioVaM. A preserved endothelial phenotype of seeded cells was verified in all cultures by acetylated low density lipoprotein uptake and positive immunohistochemistry against von Willebrand factor, endothelial nitric oxide synthase, and CD31. Conclusion Coating of decellularized vessel structures with CCN1 supports adhesion of hCBEC and enhances re-endothelialization of BioVaM. Perfusable, endothelialized constructs may aid in solving the problem of nourishing cells inside 3D tissue‐engineered constructs.</description><identifier>ISSN: 0008-6363</identifier><identifier>EISSN: 1755-3245</identifier><identifier>DOI: 10.1093/cvr/cvp370</identifier><identifier>PMID: 19920130</identifier><identifier>CODEN: CVREAU</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Biological and medical sciences ; Cardiology. Vascular system ; CCN1 ; Cell Adhesion - drug effects ; Cell Culture Techniques - methods ; Cell Differentiation - drug effects ; Cell Division - drug effects ; Cells, Cultured ; Cysteine-Rich Protein 61 - pharmacology ; Endothelial Cells - drug effects ; Endothelium ; Extracellular matrix ; Extracellular Matrix - drug effects ; Fetal Blood - cytology ; Humans ; Medical sciences ; Neovascularization, Physiologic - drug effects ; Tissue engineering ; Tissue Engineering - methods</subject><ispartof>Cardiovascular research, 2010-03, Vol.85 (4), p.806-813</ispartof><rights>Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org. 2010</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-4548c052e33bfdd363aafc3dddfe63661c9791601ad9733b4318be068925468f3</citedby><cites>FETCH-LOGICAL-c420t-4548c052e33bfdd363aafc3dddfe63661c9791601ad9733b4318be068925468f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1584,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22410027$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19920130$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bär, Antonia</creatorcontrib><creatorcontrib>Dorfman, Suzanne E.</creatorcontrib><creatorcontrib>Fischer, Philipp</creatorcontrib><creatorcontrib>Hilfiker-Kleiner, Denise</creatorcontrib><creatorcontrib>Cebotari, Serghei</creatorcontrib><creatorcontrib>Tudorache, Igor</creatorcontrib><creatorcontrib>Suprunov, Marc</creatorcontrib><creatorcontrib>Haverich, Axel</creatorcontrib><creatorcontrib>Hilfiker, Andres</creatorcontrib><title>The pro-angiogenic factor CCN1 enhances the re-endothelialization of biological vascularized matrices in vitro</title><title>Cardiovascular research</title><addtitle>Cardiovasc Res</addtitle><description>Aims A problem in generating artificial tissues is supplying nutrients to cells within 3D constructs. The use of a decellularized biological vascularized matrix with preserved pedicles (BioVaM), as a scaffold, appears to aid the generation of perfusable tissue constructs in vitro. To prevent vessel occlusion upon implantation, a functional endothelium must line the graft vessel bed. Here we tested whether the pro-angiogenic factor CCN1 could improve the re-endothelialization of BioVaM in vitro. Methods and results BioVaM vessel beds were incubated with 100 ng/mL recombinant human CCN1. Human cord blood endothelial cells (hCBEC) were analysed with respect to adhesion behaviour upon CCN1 exposure and seeded onto vessel structures of CCN1 exposed BioVaM (cBioVaM). BioVaMs were fixed in a bioreactor and perfusion cultured for 4 and 14 days (d). BioVaM without CCN1 treatment served as controls. Initial seeding success and endothelialization progression were monitored by fluorescence‐labelled hCBEC. During construct cultivation, pH and lactate production were measured. Degree of endothelialization and characterization of seeded cells, with respect to endothelial markers, were investigated histologically. BioVaM vessel structures showed a 78 ± 17% increase of attached cells when pre-treated with CCN1. Evaluation of re-endothelialization (arbitrary units) was 4.0 ± 0.8 and 2.6 ± 0.8 after 4 d, and 5.0 ± 0.0 and 3.0 ± 0.5 after 14 d in cBioVaM vs. BioVaM, respectively. On day 14, lactate concentration, an indicator of metabolic activity, was increased 12-fold in cBioVaM relative to BioVaM. A preserved endothelial phenotype of seeded cells was verified in all cultures by acetylated low density lipoprotein uptake and positive immunohistochemistry against von Willebrand factor, endothelial nitric oxide synthase, and CD31. Conclusion Coating of decellularized vessel structures with CCN1 supports adhesion of hCBEC and enhances re-endothelialization of BioVaM. Perfusable, endothelialized constructs may aid in solving the problem of nourishing cells inside 3D tissue‐engineered constructs.</description><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>CCN1</subject><subject>Cell Adhesion - drug effects</subject><subject>Cell Culture Techniques - methods</subject><subject>Cell Differentiation - drug effects</subject><subject>Cell Division - drug effects</subject><subject>Cells, Cultured</subject><subject>Cysteine-Rich Protein 61 - pharmacology</subject><subject>Endothelial Cells - drug effects</subject><subject>Endothelium</subject><subject>Extracellular matrix</subject><subject>Extracellular Matrix - drug effects</subject><subject>Fetal Blood - cytology</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Neovascularization, Physiologic - drug effects</subject><subject>Tissue engineering</subject><subject>Tissue Engineering - methods</subject><issn>0008-6363</issn><issn>1755-3245</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90E1rFDEYB_Agit1WL34AyUUEYfTJ22TmKIt2haII1YqXkM3LNppN1mRmsf30puzS3jyEJPDLE_5_hF4QeEtgZO_MvrS1YxIeoQWRQnSMcvEYLQBg6HrWsxN0WuuvdhVC8qfohIwjBcJggdLltcO7kjudNiFvXAoGe22mXPBy-Zlgl651Mq7iqbniOpdsbscYdAy3ego54ezxOuSYN8HoiPe6mjnqEm6dxVs9lXD3OiS8D1PJz9ATr2N1z4_7Gfr28cPlctVdfDn_tHx_0RlOYeq44IMBQR1ja29tS6C1N8xa613L0xMzypH0QLQdZTOckWHtoB9GKng_eHaGXh_mtmh_ZlcntQ3VuBh1cnmuSjIOlA18bPLNQZqSay3Oq10JW11uFAF1V69q9apDvQ2_PI6d11tnH-ixzwZeHUGrQUdfWnmh3jtKOQGg8sHleff_D7uDC3Vyf--lLr9VL5kUavXjp_q64ldX8P1cEfYPBkqgUw</recordid><startdate>20100301</startdate><enddate>20100301</enddate><creator>Bär, Antonia</creator><creator>Dorfman, Suzanne E.</creator><creator>Fischer, Philipp</creator><creator>Hilfiker-Kleiner, Denise</creator><creator>Cebotari, Serghei</creator><creator>Tudorache, Igor</creator><creator>Suprunov, Marc</creator><creator>Haverich, Axel</creator><creator>Hilfiker, Andres</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20100301</creationdate><title>The pro-angiogenic factor CCN1 enhances the re-endothelialization of biological vascularized matrices in vitro</title><author>Bär, Antonia ; Dorfman, Suzanne E. ; Fischer, Philipp ; Hilfiker-Kleiner, Denise ; Cebotari, Serghei ; Tudorache, Igor ; Suprunov, Marc ; Haverich, Axel ; Hilfiker, Andres</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-4548c052e33bfdd363aafc3dddfe63661c9791601ad9733b4318be068925468f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>CCN1</topic><topic>Cell Adhesion - drug effects</topic><topic>Cell Culture Techniques - methods</topic><topic>Cell Differentiation - drug effects</topic><topic>Cell Division - drug effects</topic><topic>Cells, Cultured</topic><topic>Cysteine-Rich Protein 61 - pharmacology</topic><topic>Endothelial Cells - drug effects</topic><topic>Endothelium</topic><topic>Extracellular matrix</topic><topic>Extracellular Matrix - drug effects</topic><topic>Fetal Blood - cytology</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Neovascularization, Physiologic - drug effects</topic><topic>Tissue engineering</topic><topic>Tissue Engineering - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bär, Antonia</creatorcontrib><creatorcontrib>Dorfman, Suzanne E.</creatorcontrib><creatorcontrib>Fischer, Philipp</creatorcontrib><creatorcontrib>Hilfiker-Kleiner, Denise</creatorcontrib><creatorcontrib>Cebotari, Serghei</creatorcontrib><creatorcontrib>Tudorache, Igor</creatorcontrib><creatorcontrib>Suprunov, Marc</creatorcontrib><creatorcontrib>Haverich, Axel</creatorcontrib><creatorcontrib>Hilfiker, Andres</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cardiovascular research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bär, Antonia</au><au>Dorfman, Suzanne E.</au><au>Fischer, Philipp</au><au>Hilfiker-Kleiner, Denise</au><au>Cebotari, Serghei</au><au>Tudorache, Igor</au><au>Suprunov, Marc</au><au>Haverich, Axel</au><au>Hilfiker, Andres</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The pro-angiogenic factor CCN1 enhances the re-endothelialization of biological vascularized matrices in vitro</atitle><jtitle>Cardiovascular research</jtitle><addtitle>Cardiovasc Res</addtitle><date>2010-03-01</date><risdate>2010</risdate><volume>85</volume><issue>4</issue><spage>806</spage><epage>813</epage><pages>806-813</pages><issn>0008-6363</issn><eissn>1755-3245</eissn><coden>CVREAU</coden><abstract>Aims A problem in generating artificial tissues is supplying nutrients to cells within 3D constructs. The use of a decellularized biological vascularized matrix with preserved pedicles (BioVaM), as a scaffold, appears to aid the generation of perfusable tissue constructs in vitro. To prevent vessel occlusion upon implantation, a functional endothelium must line the graft vessel bed. Here we tested whether the pro-angiogenic factor CCN1 could improve the re-endothelialization of BioVaM in vitro. Methods and results BioVaM vessel beds were incubated with 100 ng/mL recombinant human CCN1. Human cord blood endothelial cells (hCBEC) were analysed with respect to adhesion behaviour upon CCN1 exposure and seeded onto vessel structures of CCN1 exposed BioVaM (cBioVaM). BioVaMs were fixed in a bioreactor and perfusion cultured for 4 and 14 days (d). BioVaM without CCN1 treatment served as controls. Initial seeding success and endothelialization progression were monitored by fluorescence‐labelled hCBEC. During construct cultivation, pH and lactate production were measured. Degree of endothelialization and characterization of seeded cells, with respect to endothelial markers, were investigated histologically. BioVaM vessel structures showed a 78 ± 17% increase of attached cells when pre-treated with CCN1. Evaluation of re-endothelialization (arbitrary units) was 4.0 ± 0.8 and 2.6 ± 0.8 after 4 d, and 5.0 ± 0.0 and 3.0 ± 0.5 after 14 d in cBioVaM vs. BioVaM, respectively. On day 14, lactate concentration, an indicator of metabolic activity, was increased 12-fold in cBioVaM relative to BioVaM. A preserved endothelial phenotype of seeded cells was verified in all cultures by acetylated low density lipoprotein uptake and positive immunohistochemistry against von Willebrand factor, endothelial nitric oxide synthase, and CD31. Conclusion Coating of decellularized vessel structures with CCN1 supports adhesion of hCBEC and enhances re-endothelialization of BioVaM. Perfusable, endothelialized constructs may aid in solving the problem of nourishing cells inside 3D tissue‐engineered constructs.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>19920130</pmid><doi>10.1093/cvr/cvp370</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0008-6363
ispartof Cardiovascular research, 2010-03, Vol.85 (4), p.806-813
issn 0008-6363
1755-3245
language eng
recordid cdi_proquest_miscellaneous_734023849
source MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Biological and medical sciences
Cardiology. Vascular system
CCN1
Cell Adhesion - drug effects
Cell Culture Techniques - methods
Cell Differentiation - drug effects
Cell Division - drug effects
Cells, Cultured
Cysteine-Rich Protein 61 - pharmacology
Endothelial Cells - drug effects
Endothelium
Extracellular matrix
Extracellular Matrix - drug effects
Fetal Blood - cytology
Humans
Medical sciences
Neovascularization, Physiologic - drug effects
Tissue engineering
Tissue Engineering - methods
title The pro-angiogenic factor CCN1 enhances the re-endothelialization of biological vascularized matrices in vitro
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T03%3A45%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20pro-angiogenic%20factor%20CCN1%20enhances%20the%20re-endothelialization%20of%20biological%20vascularized%20matrices%20in%20vitro&rft.jtitle=Cardiovascular%20research&rft.au=B%C3%A4r,%20Antonia&rft.date=2010-03-01&rft.volume=85&rft.issue=4&rft.spage=806&rft.epage=813&rft.pages=806-813&rft.issn=0008-6363&rft.eissn=1755-3245&rft.coden=CVREAU&rft_id=info:doi/10.1093/cvr/cvp370&rft_dat=%3Cproquest_cross%3E734023849%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=734023849&rft_id=info:pmid/19920130&rft_oup_id=10.1093/cvr/cvp370&rfr_iscdi=true